Posts tagged “Pappas”

March 2

Premium Lock Art Pappas: Receiving CED Life Science Leadership award 'humbling'

It was a big week for Art Pappas, managing partner of Pappas Ventures. He accepted the 2017 Life Science Leadership Award at the CED's Life Science Conference and CoLucid, a company his firm backed and he led as founding CEO closed its $960 million acquisition by Eli Lilly and Co. the same day.

Arthur Pappas Arthur Pappas

February 24

Premium Lock Durham-based Pappas Ventures seeks $125 million to invest in biotech

Pappas Ventures ​Pappas Ventures, a Durham-based venture capital firm, plans to raise $125 million to invest in biotechnology through a venture capital fund, according to a filing with the Securities and Exchange Commission.

Updated January 24

Premium Lock Venture capitalist Art Pappas to receive CED Life Science Leadership Award

North Carolina life science pacesetter and investor Art Pappas, managing partner of venture capital firm Pappas Ventures, will receive the Council for Entrepreneurial Development's 2017 Life Science Leadership Award.

Arthur Pappas Arthur Pappas

January 11

Premium Lock 6 emerging technologies land first Wake Forest Innovations funding

Pappas Ventures A new technology investment fund managed by Pappas Capital in Durham has picked the first six emerging technologies to receive investments from a $15 million pool of capital created in late 2015.

Updated April 15, 2016

Premium Lock New VC report shows third straight decline for NC funding, but ...

Dollar sign       From bullish to bearish in just a few months for North Carolina venture deals? Could be. The second of three major venture capital funding reports is out, and it too reports that deals have dried up substantially so far this year. However, there's a caveat.

March 3, 2016

Premium Lock Pappas wins legal round; IBM sues Groupon; Rory Read's role in EMC-Dell merger; who will succeed GSK's Witty?

Bulldog In today's early edition of the Bulldog tech and life science news roundup: Venture firm A.M. Pappas wins a legal round in lawsuits; IBM sues Groupon; former Lenovo exec Rory Read's role in Dell-EMC merger; and speculating on who will succeed GSK CEO Andrew Witty.

Tags: Pappas, EMC, IBM
Updated October 8, 2015

Premium Lock Pappas, Wake Forest Baptist team on $15M fund; Chimerix gets early drug results; Square 1 Bank now PacWest division

Bulldog In today's Bulldog update of technology news: Pappas teams with Wake Forest Baptist for $15M fund; Chimerix gets early results on antiviral drug; Square 1 Bank now a Pacific Western division.

June 19, 2015

Premium Lock Startup Envisia Therapeutics hires Pappas Ventures exec as CFO

Envisia Therapeutics, a startup that was spun off from Liquidia, has hired a veteran exexutive from Pappas Ventures - one of its investors - to serve as CFO.

Envisia Therapeutics Envisia Therapeutics

June 16, 2015

Premium Lock Pappas Ventures action: New funding deal; former RTP exec joins a portfolio firm

Pappas Ventures Durham-based Pappas Ventures, which focuses on life science investments and has $350 million under management, is putting more of that funding to work in a new funding deal. Plus, a Pappas portfolio firm adds a former RTP exec to its management team.

June 5, 2015

Premium Lock Venture firm Pappas sues 'John Doe;' RT Foundation COO retiring; taco bikes in Raleigh; Microsoft's mobile app move; Softbank's $1B investment

Bulldog In today's Bulldog wrapup of technology news: Durham venture capital firm A.M. Pappas files suit against unknown critic; the COO of the research Triangle Foundation is retiring; taco bikes are coming to Raleigh via entrepreneur Justin Miller; Microsoft makes a big mobile apps play; and Softbank invests $1 billion in an ecommerce firm.

Updated December 9, 2014

Premium Lock VCs launch a diversity task force - years too late but better than never

The lack of diversity among the ranks of professional venture capitalists and their companies has been a disgrace for years. Finally, the National Venture Capital Association is launching a "Diversity Task Force." But like the technology industry on which it focuses, the NVCA has a lot of work to do to change its almost-all white, male labor force. By the way, a Durham VC is serving on the group.

Diversity  Diversity

Updated September 3, 2014

Premium Lock Pappas to manage new venture fund from Chiesi Group

Venture Capital     Durham-based venture capital firm A.M. Pappas & Associates will manage a new venture capital fund being launched by Italy-based Chiesi Ventures, the companies announced Tuesday.

Updated May 8, 2014

Premium Lock Charlotte drug firm led by former Pappas Ventures exec sells for $658M

Chelsea Therapeutics has agreed to be purchased by Danish global drug company Lundbeck for up-front cash and milestone payments to shareholders. The total depends on whether Chelsea's newly approved debut drug meets expectations when it hits the market. The buyout caps a stellar run for Joseph Oliveto, a former executive at Pappas Ventures in Durham.

Chelsea's new CEO Chelsea's new CEO

January 9, 2014

Premium Lock Facebook shares hit record; Pappas promotion; ChannelAdvisor execs on road; Google ferries workers; Samsung's new 'eye' phone

Bulldog In our Bulldog blog's regional tech and life science news update: Facebook shares are at a record high; Pappas Ventures names a new partner; ChannelAdvisor execs hit the road to talk business; Google to ferry workers to the Valley; Samsung's new phone may include eye recognition.

Updated December 11, 2013

Premium Lock Chairman and former CEO of Roche joins Pappas Ventures

Franz Humer Franz Humer, chairman and former chief executive officer of global drug giant Roche, is joining Durham-based venture capital firm Pappas Ventures as a partner and senior advisor.

Updated May 16, 2013

Premium Lock Triangle VC Pappas joins National Venture Capital Association board

Arthur Pappas Art Pappas, one of the deans of the venture capital industry in North Carolina, is among five VCs named to the board of the National Venture Capital Association.

September 19, 2012

Premium Lock CoLucid, FDA settle on next steps in migraine drug trial

CoLucid CoLucid has raised more than $41 million in venture funding since its launch in 2005. Pappas Ventures, which is based in the Triangle, launched the company. Funds raised a year ago were targeted for use in a Phase 3 trial of its lead candidate.

Updated July 23, 2012

Premium Lock Despite surge in tech startups, VCs see little chance of a 'bubble'

Venture Update With all the recent programs rolling out to support the launch and growth of new companies, funding remains scarce. If nothing else, lack of cash will keep a damper on entrepreneurs' hopes of flaming beyond control.

Updated July 20, 2012

Premium Lock VCs remain optimistic despite tough deal numbers

Venture update Two new reports on the state of venture capital paint a grim picture for deal making in North Carolina. So what's happening out there? Several VCs offer their thoughts.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith